Showing results (21-30 of 36) with videos related to
Sort By:
Pageof 4
Journal of Clinical Pathology|April 10, 2016
Dysregulation of the intrinsic apoptotic pathway mediates megakaryocytic hyperplasia in myeloproliferative neoplasmsJacques A J Malherbe, Kathryn A Fuller, Bob Mirzai, et al.Acta Haematologica|January 30, 2024
Attitudes towards COVID-19 Vaccination in Adults with Haematological MalignanciesRichard Blennerhassett, Nada Hamad, Lisa Grech, et al.BMC Medical Genetics|February 19, 2020
Two monogenic disorders masquerading as one: severe congenital neutropenia with monocytosis and non-syndromic sensorineural hearing lossParvathy Venugopal, Lucia Gagliardi, Cecily Forsyth, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 29, 2018
Hydroxycarbamide Plus Aspirin Versus Aspirin Alone in Patients With Essential Thrombocythemia Age 40 to 59 Years Without High-Risk FeaturesAnna L Godfrey, Peter J Campbell, Cathy MacLean, et al.British Journal of Haematology|February 16, 2017
Upfront lower dose lenalidomide is less toxic and does not compromise efficacy for vulnerable patients with relapsed refractory multiple myeloma: final analysis of the phase II RevLite studyHang Quach, Liam Fernyhough, Ross Henderson, et al.Blood Advances|April 5, 2019
The natural history of vascular and other complications in patients treated with nilotinib for chronic myeloid leukemiaAdrian G Minson, Katherine Cummins, Lucy Fox, et al.Blood Advances|January 4, 2018
The incidence and natural history of dasatinib complications in the treatment of chronic myeloid leukemiaLucy C Fox, Katherine D Cummins, Ben Costello, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 13, 2011
Positron emission tomography-computed tomography (PET-CT) after induction therapy is highly predictive of patient outcome in follicular lymphoma: analysis of PET-CT in a subset of PRIMA trial participantsJudith Trotman, Marion Fournier, Thierry Lamy, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 1, 2025
Acalabrutinib Plus Bendamustine-Rituximab in Untreated Mantle Cell LymphomaMichael Wang, David Salek, David Belada, et al.Blood|August 5, 2024
Asciminib monotherapy as frontline treatment of chronic-phase chronic myeloid leukemia: results from the ASCEND studyDavid T Yeung, Naranie Shanmuganathan, John Reynolds, et al.Pageof 4